Keyphrases
Adjusted Odds Ratio
40%
Adult Patients
20%
Angiotensin Receptor Blockers
20%
Angiotensin-converting Enzyme Inhibitor (ACEi)
20%
Antithrombotic Strategies
20%
Bleeding
100%
Bleeding Events
80%
Bleeding Risk
20%
Confidence Interval
40%
Continuous-flow Left Ventricular Assist Device (CF-LVAD)
100%
Epistaxis
20%
Event History
20%
Gastrointestinal Bleeding
40%
HeartMate 3
40%
HeartMate II
40%
HeartWare
20%
Intracerebral Hemorrhage
20%
Jewish
20%
Left Ventricular Assist Device Support
100%
LVAD Implantation
20%
LVAD Support
20%
Retrospective Cohort
20%
Retrospective Cohort Analysis
20%
Risk Difference
20%
Serotonergic Drugs
100%
Single Center
20%
Smoking History
20%
St. Jude Medical
40%
Use History
20%
Medicine and Dentistry
ACE Inhibitor
33%
Angiotensin Receptor Antagonist
33%
Antidepressant
100%
Antithrombotic
33%
Bleeding
100%
Cerebral Hemorrhage
33%
Ciclonicate
66%
Cohort Analysis
33%
Epistaxis
33%
Left Ventricular Assist Device
100%
Odds Ratio
66%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin Receptor Antagonist
33%
Anticoagulant Agent
33%
Antidepressant
100%
Bleeding
100%
Brain Hemorrhage
33%
Ciclonicate
66%
Dipeptidyl Carboxypeptidase Inhibitor
33%
Epistaxis
33%
Nursing and Health Professions
Angiotensin Receptor Antagonist
9%
Anticoagulant Agent
9%
Antidepressant
100%
Bleeding
100%
Brain Hemorrhage
9%
Ciclonicate
18%
Cohort Analysis
9%
Confidence Interval
18%
Dipeptidyl Carboxypeptidase Inhibitor
9%
Epistaxis
9%
Left Ventricular Assist Device
100%
Odds Ratio
18%